Genetic testing for familial Alzheimer's must be debated

doi:10.1136/bmj.325.7363.549

From trainee to consultant, BMJ Group offers doctors around the world tailored information, special events, learning resources and recruitment services at every step along their career path.

... by doctors, for doctors, for patients
We are open for entries!

Online learning

BMJ Learning

High-quality CME / CPD for doctors and other healthcare professionals. BMJ Learning features hundreds of accredited, peer-reviewed learning modules in text, video, and audio formats. Find out more

Courses and Qualifications

BMJ Masterclasses

BMJ Masterclasses, led by experts, help clinicians to use the latest evidence and recent guidelines in practice and meet their CPD/CME requirements. Find out more

Exam Preparation

The leading provider of online exam preparation, helping over 167,000 healthcare professionals to pass their exams. Find out more

onExamination

Search all BMJ comment articles:

From

Limit by

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

Josep M Garcia, registered nurse (josepmgarcia@hotmail.com),
José Luis R Martín, researcher

Corporacio Parc Taulí, E-08202 Sabadell, Barcelona, Spain
Hospital de la Santa Creu I Sant Pau, E-08025 Barcelona

EDITOR—Rigg's news item about genetic testing for familial Alzheimer's disease in a Spanish hospital highlights the need to extend the current debate in the Spanish press to the scientific community.1 In spite of its high genetic penetrance, environmental factors can also determine the phenotypic presentation of familial Alzheimer's disease.2 Since the disease is currently incurable and no interventions have been proved to either prevent or delay the onset of the disease, considerations of the quality of life of future patients are paramount.

People who have …